Publisher Full Text
The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients.Blood. 2020 05 21; 135(21):1912-1915.Blood
Links
MeSH
Pub Type(s)
Journal Article
Language
eng
PubMed ID
32302379
Citation
Treon, Steven P., et al. "The BTK Inhibitor Ibrutinib May Protect Against Pulmonary Injury in COVID-19-infected Patients." Blood, vol. 135, no. 21, 2020, pp. 1912-1915.
Treon SP, Castillo JJ, Skarbnik AP, et al. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients. Blood. 2020;135(21):1912-1915.
Treon, S. P., Castillo, J. J., Skarbnik, A. P., Soumerai, J. D., Ghobrial, I. M., Guerrera, M. L., Meid, K., & Yang, G. (2020). The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients. Blood, 135(21), 1912-1915. https://doi.org/10.1182/blood.2020006288
Treon SP, et al. The BTK Inhibitor Ibrutinib May Protect Against Pulmonary Injury in COVID-19-infected Patients. Blood. 2020 05 21;135(21):1912-1915. PubMed PMID: 32302379.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients.
AU - Treon,Steven P,
AU - Castillo,Jorge J,
AU - Skarbnik,Alan P,
AU - Soumerai,Jacob D,
AU - Ghobrial,Irene M,
AU - Guerrera,Maria Luisa,
AU - Meid,Kirsten,
AU - Yang,Guang,
PY - 2020/4/18/pubmed
PY - 2020/6/2/medline
PY - 2020/4/18/entrez
SP - 1912
EP - 1915
JF - Blood
JO - Blood
VL - 135
IS - 21
SN - 1528-0020
UR - https://www.unboundmedicine.com/medline/citation/32302379/full_citation
L2 - https://linkinghub.elsevier.com/retrieve/pii/S0006-4971(20)62018-3
DB - PRIME
DP - Unbound Medicine
ER -